Cytokine Signature in Nasal Washes of Children with Acute Bacterial Sinusitis Compared to Viral URI
Saturday, April 29, 2023
3:00 PM – 3:15 PM ET
Location: Convention Center: 146 A
Publication Number: 1480.5
Gregory DeMuri, Univ of Wisconsin School of Medicine and Public Health, Madison, WI, United States; James Gern, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States; Adam J. Glawe, University of Wisconsin-Madison, Madison, WI, United States; Jens Eickhoff, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States; Ellen R. Wald, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States
Presenting Author(s)
GD
Gregory DeMuri, MD (he/him/his)
Professor Univ of Wisconsin School of Medicine and Public Health Madison, Wisconsin, United States
Disclosure(s):
Gregory DeMuri, MD: No financial relationships to disclose
James Gern, MD: Astra-Zeneca (Terminated, December 28, 2022) (Products/Services: Consultant); Meissa Vaccines, Inc. (Ongoing) (Products/Services: Board Member or Executive Role, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Via Nova Therapeutics (Ongoing) (Products/Services: Consultant)
Adam J. Glawe, Masters - Biomedical Science: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Jens Eickoff, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Ellen R. Wald, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
